Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liposomal Bupivacaine Use in Alveolar Bone Graft Patients
Sponsor: Kerry O'Rourke
Summary
The goal of this clinical trial is to learn if a pain medication called liposomal bupivacaine (brand name EXPAREL®) with epinephrine will provide better pain control, increased activity, and reduced use of opioids compared with the standard treatment for patients age 6 years and older with cleft lip and palate who have had an alveolar bone graft surgery. Investigators will look at: * pain scores at hip and jaw sites * opioid use in amount and frequency * scores on activity questionnaires Researchers will compare the results of these items with those of patients who had the standard treatment of bupivacaine with epinephrine.
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-04-24
Completion Date
2026-04-24
Last Updated
2024-07-03
Healthy Volunteers
No
Conditions
Interventions
Liposomal Bupivacaine
Patients will receive liposomal bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.
Bupivacain
Patients will receive standard bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.
Epinephrine
Patients will receive epinephrine (ratio of 1:100,000) mixed with the appropriate drug assigned to them based on their arm.
Locations (1)
Shriners Children's Chicago
Chicago, Illinois, United States